Alto Neuroscience Appoints New CMO, Adds Director
Ticker: ANRO · Form: 8-K · Filed: Mar 11, 2024 · CIK: 1999480
| Field | Detail |
|---|---|
| Company | Alto Neuroscience, Inc. (ANRO) |
| Form Type | 8-K |
| Filed Date | Mar 11, 2024 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.0001, $40,000, $5,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, board-appointment
TL;DR
Alto Neuro just hired a new CMO and added a director to the board. Big moves for their pipeline.
AI Summary
Alto Neuroscience, Inc. announced on March 8, 2024, the appointment of Dr. David Kupfer as Chief Medical Officer and the election of Ms. Jennifer McNeley to its Board of Directors. Dr. Kupfer, formerly of Genentech, brings extensive experience in neuroscience drug development. Ms. McNeley, a seasoned executive, will serve on the Audit Committee.
Why It Matters
The appointment of a new Chief Medical Officer and a new board member with relevant experience can signal a strategic shift or strengthening of leadership for the company's drug development pipeline.
Risk Assessment
Risk Level: medium — Changes in key executive and board positions can indicate internal shifts that may impact future strategy and performance.
Key Players & Entities
- Alto Neuroscience, Inc. (company) — Registrant
- Dr. David Kupfer (person) — Appointed Chief Medical Officer
- Ms. Jennifer McNeley (person) — Elected to Board of Directors
- Genentech (company) — Former employer of Dr. Kupfer
FAQ
Who has been appointed as the new Chief Medical Officer for Alto Neuroscience?
Dr. David Kupfer has been appointed as the new Chief Medical Officer for Alto Neuroscience.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on March 8, 2024.
Who was elected to the Board of Directors of Alto Neuroscience?
Ms. Jennifer McNeley was elected to the Board of Directors of Alto Neuroscience.
What is Alto Neuroscience's principal executive office address?
Alto Neuroscience's principal executive office is located at 369 South San Antonio Road, Los Altos, CA 94022.
What is the Commission File Number for Alto Neuroscience?
The Commission File Number for Alto Neuroscience is 001-41944.
Filing Stats: 945 words · 4 min read · ~3 pages · Grade level 10.6 · Accepted 2024-03-11 08:20:03
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 par value per share ANRO New York S
- $40,000 — ition, Dr. Radhakrishnan will be paid a $40,000 annual cash retainer for her service on
- $5,000 — er for her service on the Board, plus a $5,000 annual cash retainer for her service on
Filing Documents
- d764642d8k.htm (8-K) — 25KB
- 0001193125-24-064372.txt ( ) — 146KB
- anro-20240308.xsd (EX-101.SCH) — 3KB
- anro-20240308_lab.xml (EX-101.LAB) — 18KB
- anro-20240308_pre.xml (EX-101.PRE) — 11KB
- d764642d8k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ALTO NEUROSCIENCE, INC. Dated: March 11, 2024 By: /s/ Amit Etkin Amit Etkin, M.D., Ph.D. President and Chief Executive Officer